This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wheeler, D. L. Articles by Verma, A. K. Search for Related Content PubMed PubMed Citation Articles by Wheeler, D. L. Articles by Verma, A. K.

(American Journal of Pathology. 2005;166:117-126.)
© 2005 American Society for Investigative Pathology

Overexpression of Protein Kinase C- in the Mouse Epidermis Leads to a Spontaneous Myeloproliferative-Like Disease

Deric L. Wheeler^*, Peter J. Reddig, Kristin J. Ness^*, Catherine P. Leith, Terry D. Oberley and Ajit K. Verma^*

From the Departments of Human Oncology^* and Pathology and Laboratory Medicine, Medical School, University of Wisconsin, Madison, Wisconsin; the Veteran’s Administration Hospital, Madison, Wisconsin; and the Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina

Protein kinase C (PKC)-, a Ca²⁺-independent, phospholipid-dependent serine/threonine kinase, is among the PKC isoforms expressed in mouse epidermis. We reported that FVB/N transgenic mouse lines that overexpress (8- or 18-fold) PKC- protein in basal epidermal cells and cells of the hair follicle develop papilloma-independent squamous cell carcinoma (SCC) elicited by 7,12-dimethylbenz(a)anthracene initiation and 12-O-tetradecanoylphorbol-13-acetate-promotion or by repeated ultraviolet radiation exposures. The susceptibility to the development of SCC was proportional to the level of expression of the PKC- transgene. We now report that PKC- FVB/N transgenic mice (line 215) that overexpress in epidermis 18-fold PKC- protein more than their wild-type littermates spontaneously develop a myeloproliferative-like disease (MPD) in 100% of PKC- transgenic mice. The MPD was characterized by an excess of neutrophils and eosinophils, resulting in invasion of almost all vital organs of the mouse by 6 months of age. On gross examination these mice present with splenomegaly, hepatomegaly, and severe lymphadenopathy. Examination of the bone marrow revealed almost complete effacement by neutrophils, eosinophils, and their precursors. Furthermore, the spleen and lymph nodes were enlarged and exhibited marked extramedullary hematopoiesis. Complete pathological analysis of the second PKC- transgenic mouse (line 224) that expresses approximately eightfold PKC- protein more than their wild-type littermates revealed no remarkable findings in any of the affected organs as seen in line 215. However, peripheral blood analyses of PKC- transgenic mice indicated significant increases of neutrophils in the circulating blood in both PKC- transgenic lines. To determine whether there was an imbalance of cytokines in PKC- transgenic mice (line 215), resulting in aberrant myelopoiesis, we analyzed 17 cytokines in the peripheral blood. This analysis indicated that interleukin-5, interleukin-6, and granulocyte-colony stimulating factor were up-regulated as a function of age. The transgene PKC- was not detected in any of the affected organs (bone marrow, liver, spleen, lung) We suggest that overexpression of PKC- in the epidermis may lead to the induction of specific cytokines that may, in a paracrine mechanism, perturb normal hematopoiesis in bone marrow resulting in a granulocytic skew toward that of neutrophils and eosinophils. The susceptibility of PKC- transgenic mice to the induction of SCC and the spontaneous development of MPD are unrelated.

This article has been cited by other articles:

				B. A. Teicher Protein kinase C as a therapeutic target. Clin. Cancer Res., September 15, 2006; 12(18): 5336 - 5345. [Full Text] [PDF]